Similar articles

• Comparative evaluation of injectable chlorpromazine and piperacetazine.

  McLaughlin B, Kulkarni AS. McLaughlin B, et al. Psychosomatics. 1973 Jul-Aug;14(4):220-1. doi: 10.1016/s0033-3182(73)71335-9. Psychosomatics. 1973. PMID: 4152813 No abstract available.
• Adverse reactions to chlorpromazine in psychiatric patients.

  Swett C Jr. Swett C Jr. Dis Nerv Syst. 1974 Nov;35(11):509-11. Dis Nerv Syst. 1974. PMID: 17896459
• Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.

  Kulkarni AS. Kulkarni AS. Adv Biochem Psychopharmacol. 1974;9(0):691-9. Adv Biochem Psychopharmacol. 1974. PMID: 4151770 Clinical Trial. No abstract available.
• Psychopharmacological treatment of schizophrenia.

  Lehmann HE. Lehmann HE. Schizophr Bull. 1975 Summer;(13):27-45. Schizophr Bull. 1975. PMID: 1851 Review. No abstract available.
• Prolactin levels and effects of neuroleptics.

  Brown WA. Brown WA. Psychosomatics. 1983 Jun;24(6):569-74, 577-81. doi: 10.1016/S0033-3182(83)73187-7. Psychosomatics. 1983. PMID: 6136065 Review. No abstract available.